Disposition and metabolism of 4-methyl-2(4-phenylbenzyl)-2-oxazoline-4-methanol in the rat and dog.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D001345:Autoradiography; D001713:Biphenyl Compounds / Q000627:therapeutic use; D002250:Carbon Radioisotopes; D002351:Carrageenan; D002855:Chromatography, Thin Layer; D004285:Dogs; D005243:Feces / Q000032:analysis; D005260:Female; D005750:Gastric Juice / Q000378:metabolism; D013058:Mass Spectrometry; D000432:Methanol / Q000378:metabolism / Q000627:therapeutic use / Q000652:urine; D010080:Oxazoles / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D010653:Phenylbutazone / Q000627:therapeutic use; D010996:Pleural Effusion / Q000139:chemically induced / Q000188:drug therapy; D051381:Rats
D000893:Anti-Inflammatory Agents; D001713:Biphenyl Compounds; D002250:Carbon Radioisotopes; D010080:Oxazoles; D002351:Carrageenan; D010653:Phenylbutazone; D000432:Methanol